Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Observational Study on Treatment Approaches and Biomarkers in de Novo Metastatic Hormone Sensitive Prostate Cancer in Russian Federation

NCT07146113 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07146113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07146113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Observational Study on Treatment Approaches and Biomarkers in de Novo Metastatic Hormone Sensitive Prostate Cancer in Russian Federation
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Suspended
Start date
June 30, 2025
Completion date
June 30, 2027
Enrollment
400 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer